Research of Exenatide for Overweight/Obese PCOS Patients With IGR

NCT03352869 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

183

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome
Overweight and Obesity
Disorder of Glucose Regulation

Interventions

DRUG: Exenatide
DRUG: Metformin

Sponsor

RenJi Hospital